LDH-IN-2 structure
|
Common Name | LDH-IN-2 | ||
---|---|---|---|---|
CAS Number | 893739-96-3 | Molecular Weight | 204.18 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C11H8O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of LDH-IN-2LDH-IN-2, a salicylic acid derivative, is an inhibitor of glycolate oxidase (GO). LDH-IN-2 decreases oxalate output in hyperoxaluric hepatocytes. LDH-IN-2 can be used for research of primary hyperoxaluria type 1 (PH1)[1]. |
Name | LDH-IN-2 |
---|
Description | LDH-IN-2, a salicylic acid derivative, is an inhibitor of glycolate oxidase (GO). LDH-IN-2 decreases oxalate output in hyperoxaluric hepatocytes. LDH-IN-2 can be used for research of primary hyperoxaluria type 1 (PH1)[1]. |
---|---|
Related Catalog | |
In Vitro | LDH-IN-2L (compound 34) (10 μM; 24 h) 在 Agxt1-/- 小鼠原代肝细胞中抑制草酸产生的抑制率为 89%[1]。 |
References |
Molecular Formula | C11H8O4 |
---|---|
Molecular Weight | 204.18 |